Browns Veterinary Pharmaceuticals launches Bravecto for long lasting protection against ticks & fleas

Published Date : 06-Nov-2019

The Browns Veterinary Pharmaceuticals Division recently launched Bravecto at the Waters Edge Hotel, Battaramulla. The launch was held as a part of this year’s annual gathering of the Society of Companion Animal Practitioners’ Sri Lanka which is affiliated with the World Society of Companion Animal Practitioners. Bravecto is the world’s leading brand in providing immediate and persistent control of ticks and fleas on dogs.

Bravecto is the first and only chewable tick and flea protection to last a minimum of 3 months on a single dose. Sri Lankan pet lovers will now have an extraordinary, long lasting way to protect dogs against ticks and fleas.

Commenting on the launch Mangala Wijesinghe, General Manager – Pharmaceuticals of Brown & Company PLC, said, “At Browns we are constantly evaluating our product portfolio to ensure that we are providing our loyal consumers with the best solutions to address their needs. That is why we are proud to launch Bravecto to the local market. This innovative product, in addition to its efficacy, adds a level of simplicity and convenience to the procedure of controlling the menace of ticks and fleas that is not available elsewhere in the market. Because of this we are certain that pets and their owners will fall in love with Bravecto and guarantee its success in Sri Lanka.”

Bravecto is a product of MSD Animal Health, which is the leading veterinary pharmaceutical company in the world and one of the main suppliers to the Browns Veterinary Pharmaceuticals Division with a relationship spanning three decades. MSD currently supplies more than 140 countries around the world and operates in more than 50 countries.

Brown & Company PLC is a diversified conglomerate managing a fast growing and valuable portfolio of brands across several key industry sectors such as power generation, home and office solutions, agriculture and plantation support services, pharmaceuticals, investments, marine and manufacturing, and healthcare. A deep understanding of Sri Lankan consumer needs, derived from being in business for over 140 years, has made the Group thrive in all its sectors of operation. The Browns Group has been able to evolve and adapt to changing times and, most importantly, to changing customer needs.

Photo Caption

(From right) Danesh Abeyrathne, Chief Operating Officer, Brown and Company PLC, Mangala Wijesinghe, General Manager, Browns Pharmaceuticals Division, Dr. Yash Goyal, Managing Director, MSD Animal Health at the Bravecto launch.

Related News